United States v. William Clinton Roark

924 F.2d 1426, 1991 U.S. App. LEXIS 1403, 1991 WL 7957
CourtCourt of Appeals for the Eighth Circuit
DecidedJanuary 30, 1991
Docket90-1334WM
StatusPublished
Cited by88 cases

This text of 924 F.2d 1426 (United States v. William Clinton Roark) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. William Clinton Roark, 924 F.2d 1426, 1991 U.S. App. LEXIS 1403, 1991 WL 7957 (8th Cir. 1991).

Opinion

BOGUE, Senior District Judge.

William Clinton Roark was convicted of the following in violation of 21 U.S.C. §§ 841(a)(1) and 846: (1) Conspiracy to manufacture and possession with intent to distribute methamphetamine and phenyl-2-propanone, commonly known as “P2P” (§ 846); (2) manufacture of P2P (§ 841(a)(1)); and attempt to manufacture methamphetamine (§§ 846 and 841(a)(1)). Appellant raises three issues on appeal. First, that Appellant was not properly indicted and tried because Methamphetamine and Phenyl-2-Propanone [P2P] are and were not lawfully proscribed under Schedule II of the Federal Controlled Substances Act. (This issue was not raised in the district court). Second, that the court erred in refusing to instruct the jury as to multiple conspiracies. Finally, that the court erred in refusing to declare a mistrial after rescinding its order to produce material under the Jencks Act.

I. BACKGROUND:

Appellant’s indictment resulted from the discovery on May 22,1987, of an extensive, operating clandestine drug lab on rural property in Missouri. The drug operation, which had been operating since March of 1985, involved several co-defendants, all of whom belonged to the Hells Angels Motorcycle Club. Four of the co-defendants were arrested in June of 1986, and Appellant, who remained a fugitive for two *1428 years, was not arrested until May 20, 1989, after a car-motorcycle chase in California.

Ultimately, Appellant was tried and convicted, and sentenced to concurrent terms of 20 years imprisonment on each count, a three year special parole term on Count II, and $150 mandatory penalty. (Sentencing was not under the Sentencing Reform Act of 1984). Other defendants charged in the superseding indictment were either tried or pleaded guilty prior to Appellant’s trial.

A.

The issue of the reclassification of methamphetamine was not raised in district court and is not open for normal review. United States v. Bear Runner, 502 F.2d 908, 910 (8th Cir.1970). This is the kind of point that is so fundamental, however, that it would be open for plain-error review on appeal. Therefore, we will address it on its merits.

Appellant urges that methamphetamine is not a controlled substance and, therefore, should be excluded from the controlled substance schedule because under the Food and Drug Act, it may be sold over the counter without a prescription. See 21 U.S.C. § 811(g)(1). To support this conclusion, Appellant argues that both Rynal and Vicks Inhaler nose sprays contain isomers of methamphetamine. 1

In other words, Appellant concludes that because Vicks Inhaler contains a diluted isomer of methamphetamine and is sold over-the-counter, the Drug Enforcement Administration (DEA) or Bureau of Narcotics and Dangerous Drugs (BNDD) cannot classify Methamphetamine as a controlled substance. This analysis is erroneous. Section 811(g)(1) requires exclusion of any substance from the schedules of controlled substances if it can be lawfully sold over the counter without a prescription:

(g)(1) The Attorney General shall by regulation exclude any non-narcotic substance from a schedule if such substance may, under the Federal Food, Drug, and Cosmetic Act, be lawfully sold over the counter without a prescription.

The FDA has not approved methamphetamine for sale over-the-counter, but rather has approved a combination of ingredients found in inhalers containing a diluted isomer of methamphetamine. 2 Obviously, such a combination of ingredients does not create the potential for abuse and harm that the controlled forms of methamphetamine present. We therefore reject Appellant’s contentions, and conclude that methamphetamine is properly classified as a Schedule II controlled substance pursuant to 21 C.F.R. 1308.12(d). See United States v. Kendall, 887 F.2d 240 (9th Cir.1989); United States v. Schrock, 855 F.2d 327 (6th Cir.1988).

The issue as to whether the Attorney General, the BNDD or the Drug Enforcement Administration (DEA) followed the correct procedures and made the findings necessary to reschedule methamphetamine has been presented to and ruled upon by the Ninth Circuit Court of Appeals. See Kendall, supra. We believe the findings and conclusions in that case relative to rescheduling of methamphetamine fully apply to that issue in the present case.

*1429 On May 26, 1971, the director of the Bureau of Narcotics and Dangerous Drugs (BNDD) published a notice in the Federal Register of the proposed transfer of amphetamine and methamphetamine, their salts, optical isomers, and salts of their optical isomers from Schedule III to Schedule II. (36 Fed.Reg. 9653 (1971)) Addendum, pp. 1-2.) The director further stated that the proposed transfer was based upon the investigation of his agency “... and upon the scientific and medical evaluation and recommendation of the Secretary of Health, Education and Welfare, received pursuant to Sec. 210(b) of the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. § 811(b)).”

The director then enumerated his findings as required by § 812(b)(2): that methamphetamine has a high potential for abuse; that it has a currently accepted medical use, with severe restrictions; and, that the abuse of this substance might lead to severe psychological dependence.

The statute further provides that the Attorney General, after proceedings required by 21 U.S.C. §§ 811(a) and 812(b), may add substances to Section 812 schedules or transfer substances between these schedules. 21 U.S.C. § 811(b). Under the authority of Section 871(a) and 28 U.S.C. § 510, the Attorney General properly delegated this authority to the Director of the Bureau of Narcotics and Dangerous Drugs (BNDD). 28 C.F.R. 0.100 (1971). In 1971, BNDD followed the procedures and made the findings required to reschedule methamphetamine. Accordingly, an order was made by the director and published on July 7, 1971, in the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Walter L. Johnson
Court of Appeals of Wisconsin, 2025
Bryan Porras v. State of Arkansas
2024 Ark. App. 57 (Court of Appeals of Arkansas, 2024)
United States v. Darryl Parker
871 F.3d 590 (Eighth Circuit, 2017)
United States v. Antuan Gaines
859 F.3d 1128 (Eighth Circuit, 2017)
United States v. Christopher Payne-Owens
845 F.3d 868 (Eighth Circuit, 2017)
Burris v. State
78 A.3d 371 (Court of Appeals of Maryland, 2013)
State v. Privette
721 S.E.2d 299 (Court of Appeals of North Carolina, 2012)
People v. Elmes
55 V.I. 342 (Superior Court of The Virgin Islands, 2011)
United States v. Ellison
616 F.3d 829 (Eighth Circuit, 2010)
United States v. Dale
614 F.3d 942 (Eighth Circuit, 2010)
United States v. Johnson
713 F. Supp. 2d 595 (E.D. Louisiana, 2010)
United States v. Edwards
563 F. Supp. 2d 977 (D. Minnesota, 2008)
United States v. Alexander Sandoval
166 F. App'x 876 (Eighth Circuit, 2006)
United States v. Rashad McKay
431 F.3d 1085 (Eighth Circuit, 2005)
United States v. Edward Lee May
97 F. App'x 690 (Eighth Circuit, 2004)
Blackmon v. Booker
312 F. Supp. 2d 874 (E.D. Michigan, 2004)
United States v. Alcorn
93 F. App'x 37 (Sixth Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
924 F.2d 1426, 1991 U.S. App. LEXIS 1403, 1991 WL 7957, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-william-clinton-roark-ca8-1991.